Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, October 13, 2021
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
Tue, October 12, 2021
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
Maneka Mirchandaney Initiated (VRDN) at Buy and Held Target at $40 on, Oct 12th, 2021
Maneka Mirchandaney of Evercore ISI Group, Initiated "Viridian Therapeutics, Inc." (VRDN) at Buy and Held Target at $40 on, Oct 12th, 2021.
Maneka, nor any peers, have made any analyst calls on VRDN in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30